DNLI SG&A Expense Growth
Denali Therapeutics Inc · SG&A Expense Growth
DNLI SG&A Expense Growth
Latest reported-7.90%period ending
DNLI FY SG&A Growth (YoY) (0.00% → -7.90%)
Latest values, visible window
High-resolution chart · PNG
DNLI sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -7.9042% | |
| 2.0164% | |
| 14.2349% | |
| 14.4398% | |
| 31.0529% | |
| 29.7892% | |
| 43.683% | |
| 106.3074% | |
| 33.6629% | |
| 129.6594% | |
| 0% |